• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parkinson’s Disease Foundation adds 27 research adovcates

Parkinson’s Disease Foundation adds 27 research adovcates

October 20, 2011
CenterWatch Staff

The Parkinson's Disease Foundation welcomes 27 new members to its national network of research advocates who are influencing research and speeding the development of new and effective treatments for Parkinson's.  This week in New Jersey, the members from the Northeast region are completing an intensive three-day training to prepare them to join the network, known as Parkinson's Advocates in research.

During the training, the newest PDF Research Advocates are taking part in rigorous sessions on the science of Parkinson's and the process that brings new treatments to market.  They are doing so under the guidance of leaders from institutions such as the National Institutes of Health in Bethesda, MD.  Armed with advocacy skills, they will return to their communities to take on research-related activities - including serving on research advisory boards and speaking about clinical research at conferences and support groups - through which they can share their unique perspectives as people touched by Parkinson's disease.

As PDF executive director Robin Elliott noted, "We believe that when members of the Parkinson's community are equal stakeholders - alongside research professionals, government agencies and private industry - their presence will improve the design, conduct and outcomes of clinical studies."

The diverse group of educators, scientists, lawyers and other professionals were chosen through a competitive application process open to those from the states in the Northeast region, stretching from Maine to Virginia.  All PDF research advocates are living with or are care partners to those with Parkinson's.  In the upcoming year, the Northeastern regional training will be followed by three additional trainings around the United States.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing